Diamond 1996.
Methods | Unit of randomisation: women Method of randomisation: computer‐generated Timing of randomisation: end of surgery Blinding: surgeon unaware of randomisation at second‐look laparoscopy Multi‐centre trial | |
Participants | Women undergoing uterine myomectomy at laparotomy with at least 1 posterior uterine incision ≥ 1 cm. Similar baseline characteristics, including age, size and number of myomas, and number of uterine incisions N = 127 Microsurgery: no Dropouts: 6 (withdrew or excluded because of new medications) Age, years: 34 Location: USA (19 centres) Timing: 1993 to 1995 Pre‐existing adhesions Cause of adhesions: not stated |
|
Interventions | Sodium hyaluronate and carboxymethylcellulose vs no treatment | |
Outcomes | Adhesion formation at the time of second‐look laparoscopy (mean days 23, range 7 to 70) Outcomes included number of adhesion sites, severity score, and surface area of uterine adhesions No pregnancy outcomes reported | |
Notes | Power calculations: not stated Documented by video Multi‐centre trial Sponsored by Genzyme No intention‐to‐treat analysis | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Clear method of randomisation derived from computer‐generated randomisation list No clear source of bias Quote: "at each centre each enrolled patient was assigned consecutively a study number that corresponded to an identically numbered sealed study envelope, which determined the patient's treatment assignment via a computer derived randomisation list. After completion of myomectomy, patients were randomised at each centre into two groups" |
Allocation concealment (selection bias) | Low risk | Numbered, sealed envelopes created before patient enrolment used to provide allocation, decreasing risk of bias Quote: "at each centre each enrolled patient was assigned consecutively a study number that corresponded to an identically numbered sealed study envelope, which determined the patient's treatment assignment via a computer derived randomisation list. After completion of myomectomy, patients were randomised at each centre into two groups" |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Study authors do not explicitly state that patients were blinded, but all patients had the initial myomectomy and the SLL: "after completion of the myomectomy and associated procedures, but before closure of the abdominal cavity, patients were randomized at each center into two groups: no treatment controls and patients to receive the Seprafilm study device" Surgeons were not blinded, but randomisation took place intraoperatively to minimise performance bias: "after myomectomy, just before closure of the abdominal cavity, women randomized for no treatment (n = 68) received neither Seprafilm nor a placebo" |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Videotapes of the SLL were reviewed by an independent blinded observer: "videotapes recorded during laparoscopy subsequently were reviewed at a central site by a single independent observer blinded to the patient's treatment assignment, to serve as the basis for the efficacy data on Seprafilm" |
Incomplete outcome data (attrition bias) All outcomes | Low risk | 6 (out of 127) participants were withdrawn |
Selective reporting (reporting bias) | Unclear risk | Data presented graphically and as percentages. P values stated for outcomes. No omission of outcomes and no subsets of data. Although this was an infertility study, no pregnancy outcomes stated |
Other bias | Low risk | No other bias identified |